{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:04:32Z","timestamp":1791428672887,"version":"4.3.3"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171127","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T18:58:36Z","timestamp":1486666716000},"page":"e0171127","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain"],"prefix":"10.1371","volume":"12","author":[{"given":"Nicole A.","family":"Datson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchel","family":"Gonz\u00e1lez-Barriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kourkouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudie","family":"Weij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"van de Giessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kontkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taneli","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C. T.","family":"van Deutekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"A Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"HD Rosas","year":"2003","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"F Saudou","year":"2016","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1038\/cddis.2013.276","article-title":"Mechanisms of RNA-induced toxicity in CAG repeat disorders","volume":"4","author":"R Nalavade","year":"2013","journal-title":"Cell death & disease"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington's disease","volume":"11","author":"S Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: what's in the pipeline?","volume":"29","author":"EJ Wild","year":"2014","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"C Zuccato","year":"2010","journal-title":"Physiological reviews"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e24308","DOI":"10.1371\/journal.pone.0024308","article-title":"Targeting several CAG expansion diseases by a single antisense oligonucleotide","volume":"6","author":"MM Evers","year":"2011","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"KT Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"J Hu","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression","volume":"150","author":"D Yu","year":"2012","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"MS Lombardi","year":"2009","journal-title":"Exp Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin","volume":"19","author":"JB Carroll","year":"2011","journal-title":"Mol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"AL Southwell","year":"2014","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1046\/j.1471-4159.2000.0742108.x","article-title":"Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice","volume":"74","author":"BG Jenkins","year":"2000","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","article-title":"Neurochemical changes in Huntington R6\/2 mouse striatum detected by in vivo 1H NMR spectroscopy","volume":"100","author":"I Tkac","year":"2007","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JHD-140117","article-title":"Longitudinal metabolite changes in Huntington's disease during disease onset","volume":"3","author":"SJ van den Bogaard","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"LB Menalled","year":"2012","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"T Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","article-title":"TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease","volume":"19","author":"B Baldo","year":"2012","journal-title":"Chem Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"L Menalled","year":"2009","journal-title":"Neurobiology of disease"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10048-009-0216-y","article-title":"Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3)","volume":"11","author":"C Bettencourt","year":"2010","journal-title":"Neurogenetics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1172\/JCI83185","article-title":"Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels","volume":"126","author":"L Rue","year":"2016","journal-title":"The Journal of clinical investigation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.26118","article-title":"A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers","volume":"30","author":"A Sturrock","year":"2015","journal-title":"Mov Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"JA Bibb","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"A van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","article-title":"DARPP-32: an integrator of neurotransmission","volume":"44","author":"P Svenningsson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington's disease","volume":"32","author":"L Zacharoff","year":"2012","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington's disease","volume":"48","author":"RH Myers","year":"1991","journal-title":"Arch Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"D Zielonka","year":"2013","journal-title":"Parkinsonism & related disorders"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia","volume":"57","author":"M Markianos","year":"2005","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"JL Dorner","year":"2007","journal-title":"Behav Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression","volume":"6","author":"T Renoir","year":"2011","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","article-title":"Sex differences in Parkinson's disease and other movement disorders","volume":"259","author":"KM Smith","year":"2014","journal-title":"Exp Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington's disease for translation to the clinic: best practices","volume":"29","author":"L Menalled","year":"2014","journal-title":"Mov Disord"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2012.01.015","article-title":"An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease","volume":"229","author":"K Zarringhalam","year":"2012","journal-title":"Behav Brain Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease","volume":"29","author":"DM Cummings","year":"2009","journal-title":"J Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","article-title":"R6\/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures","volume":"32","author":"E Cepeda-Prado","year":"2012","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1021\/bi401129r","article-title":"Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts","volume":"52","author":"S Busan","year":"2013","journal-title":"Biochemistry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T05:16:42Z","timestamp":1601615802000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171127"}},"subtitle":[],"editor":[{"given":"Yuqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171127","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}